Clinical Trial

Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 11, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population. And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-29.
Trial Details
NCT Number NCT07104396
Lead Sponsor Square2 Systems, Inc.
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Substance Use Disorders (SUDs)
Enrollment 20 participants
Start Date 2025-07-02
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-11